Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Huey McDaniel

Vascular Surgery Pensacola, FL Medical Doctor

NPI 1710905807 CMS profile 349587

5149 N 9Th Ave Ste 120, Pensacola, FL 32504

Open in the dashboard

General payments

$35,031

256 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$52,791 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Huey McDaniel of Pensacola, FL is reported in the CMS Open Payments database as having received $35,031 across 256 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $52,791 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,974 51
2024 General $4,051 44
2023 General $3,398 40
2022 General $5,039 32
2021 General $14,448 42
2020 General $1,483 16
2019 General $1,638 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Huey McDaniel
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Huey McDaniel were reported at $4,974. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Huey McDaniel Vascular Surgery median Middle half National median
2019 $1,638 $796 $226–$2,363 $163
2020 $1,483 $348 $118–$1,110 $114
2021 $14,448 $471 $158–$1,421 $132
2022 $5,039 $725 $222–$2,183 $149
2023 $3,398 $836 $257–$2,440 $160
2024 $4,051 $909 $252–$2,619 $164
2025 $4,974 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Silk Road Medical, Inc. $13,818 35 payments
  2. Endologix, Inc. $4,467 22 payments
  3. W. L. Gore & Associates, Inc. $2,995 32 payments
  4. Penumbra, Inc. $2,700 23 payments
  5. Bolton Medical Inc $1,765 17 payments
  6. AngioDynamics, Inc. $1,654 18 payments
  7. Boston Scientific Corporation $1,260 16 payments
  8. Inari Medical, Inc. $972 4 payments
  9. Surmodics, Inc. $846 7 payments
  10. Shockwave Medical, Inc $800 10 payments
  11. Other $3,754 72 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $21,406 231 payments
  2. Consulting Fee $8,850 5 payments
  3. Travel and Lodging $4,775 20 payments
Products named General payments · program years 2019–2025
  1. ENROUTE Transcarotid Stent $13,358 32 payments
  2. ENROUTE Transcarotid Neuroprotection System $13,358 32 payments
  3. ENHANCE Transcarotid Peripheral Access Kit $12,436 25 payments
  4. ENROUTE .014 Guidewire $12,436 25 payments
  5. Alto Abdominal Stent Graft System $3,090 11 payments
  6. Indigo System $1,746 14 payments
  7. AURYON LASER SYSTEM 100-120 VAC $1,461 17 payments
  8. FLOWTRIEVER CATHETER, S $990 5 payments
  9. RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM $962 11 payments
  10. CT THROMBECTOMY SYSTEM KIT $953 3 payments
  11. Other $18,544 221 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

78

Median for Vascular Surgery: 122

Drug cost

$7,259

Median for Vascular Surgery: $14,135

Branded share of claims

46.2%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 12 $6,835
Clopidogrel Clopidogrel Bisulfate Brand 24 $194
Atorvastatin Calcium Generic 25 $121
Cilostazol Generic 17 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 96 billing codes

Paid by Medicare

$180,390

Medicare's payments for the services billed

Medicare patients

201

Average age 75

Services billed

613

104 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Diabetes 48%
Ischemic heart disease 47%
Chronic kidney disease 44%
Atrial fibrillation 37%
COPD 34%
Heart failure 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

256 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record